Jamesr Swartz News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jamesr swartz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jamesr Swartz Today - Breaking & Trending Today
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Rating) have received a consensus rating of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year […] ....
Sutro Biopharma (NASDAQ:STRO – Get Rating) and Voyager Therapeutics (NASDAQ:VYGR – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, earnings, risk and dividends. Institutional and Insider Ownership 87.6% of Sutro Biopharma shares […] ....
Sutro Biopharma (NASDAQ:STRO – Get Rating) and Cardiol Therapeutics (NASDAQ:CRDL – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Valuation & Earnings This table compares Sutro Biopharma and […] ....
Voyager Therapeutics (NASDAQ:VYGR – Get Rating) and Sutro Biopharma (NASDAQ:STRO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Risk & Volatility Voyager Therapeutics has a beta of […] ....
Tekla Capital Management LLC trimmed its stake in shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Rating) by 10.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 147,531 shares of the company’s stock after selling 16,393 shares during the quarter. Tekla Capital Management LLC’s holdings in Sutro Biopharma were worth $1,192,000 at the end […] ....